Drug Shortage Report for METHOTREXATE INJECTION BP

Last updated on 2018-08-02 History
Report ID 56088
Drug Identification Number 02327236
Brand name METHOTREXATE INJECTION BP
Common or Proper name METHOTREXATE
Company Name ACCORD HEALTHCARE INC
Market Status MARKETED
Active Ingredient(s) METHOTREXATE
Strength(s) 25MG
Dosage form(s) SOLUTION
Route of administration INTRA-ARTERIAL INTRAMUSCULAR INTRATHECAL INTRAVENOUS INTRAVENTRICULAR
Packaging size 40 ML PER VIAL | 40 ML PAR FLACON
ATC code L01BA
ATC description ANTIMETABOLITES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-07-19
Actual start date 2018-07-19
Estimated end date 2018-08-10
Actual end date 2018-07-31
Shortage status Resolved
Updated date 2018-08-02
Company comments
Health Canada comments
Tier 3 Status No
Company contact information Customer Service at (514) 505-4159 ext. 203 | Service à la clientèle à (514) 505-4159 poste 203

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2018-08-02 French Compare
v4 2018-08-02 English Compare
v3 2018-07-20 English Compare
v2 2018-07-19 French Compare
v1 2018-07-19 English Compare

Showing 1 to 5 of 5